United States · FDA National Drug Code directory

Duloxetine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
47335-383_cec0154d-5c8c-496d-89bd-ba2a93aee774
Product NDC
47335-383
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
Duloxetine
Labeler
Sun Pharmaceutical Industries, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20131211
Source listing expiry
20261231

Source-listed ingredients

  • DULOXETINE HYDROCHLORIDE — 60 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (47335-383-08) · 47335-383-08
  • 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (47335-383-18) · 47335-383-18
  • 100 BLISTER PACK in 1 CARTON (47335-383-61) / 1 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK · 47335-383-61
  • 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (47335-383-83) · 47335-383-83
  • 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (47335-383-88) · 47335-383-88

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →